RFA
MRNA icon

Reilly Financial Advisors’s Moderna MRNA Stock Holding History

Reilly Financial Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$26K Buy
+102
New +$29.8K ﹤0.01% 519
2021
Q3 		– Sell
-102
Closed -$24K – 1003
2021
Q2 		$24K Buy
102
+67
+191% +$12K ﹤0.01% 514
2021
Q1 		$5K Hold
35
– – ﹤0.01% 795
2020
Q4 		$4K Buy
35
+30
+600% +$3.04K ﹤0.01% 734
2020
Q3 		$0 Buy
+5
New +$349 ﹤0.01% 901

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reilly Financial Advisors's MRNA Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Moderna (MRNA) in Q4 2021: 102 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #519 among its holdings. This is a return to the name: Reilly Financial Advisors previously reported a position in MRNA as recently as Q2 2021.

Reilly Financial Advisors first reported a position in MRNA in Q3 2020 and has held it in 5 quarters since. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Reilly Financial Advisors held 102 shares of Moderna worth $26K as of Q4 2021.
  • Moderna was a new Reilly Financial Advisors position in Q4 2021.
  • Moderna made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #519 holding.
  • Reilly Financial Advisors first reported a position in Moderna in Q3 2020 and has held it in 5 quarters since.
  • 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.